50 Best Peptides

This website is for informational purposes only and does not constitute medical advice. Read disclaimer

#125

Neuropeptide Y

NeuropeptideNPY

A 36-amino acid neuropeptide that is one of the most abundant peptides in the central nervous system, involved in appetite regulation, stress responses, anxiety, and cardiovascular function.

Share:

Overview

Neuropeptide Y (NPY) is a 36-amino acid peptide discovered in 1982 by Kazuhiko Tatemoto and Viktor Mutt from porcine brain extracts. Named for the tyrosine (Y) residues at both its amino and carboxyl termini, NPY is one of the most abundant and widely distributed neuropeptides in the mammalian brain. It belongs to the pancreatic polypeptide family alongside peptide YY (PYY) and pancreatic polypeptide (PP).

NPY acts through a family of at least five G-protein coupled receptor subtypes (Y1, Y2, Y4, Y5, and Y6). Its most well-characterized role is as a potent stimulator of food intake. NPY is abundantly expressed in the arcuate nucleus of the hypothalamus, where it acts as a key orexigenic (appetite-stimulating) signal. Central administration of NPY in animal models produces dramatic increases in food intake, and elevated hypothalamic NPY levels are observed during fasting. The Y1 and Y5 receptors are primarily responsible for mediating NPY's feeding effects.

Beyond appetite regulation, NPY plays critical roles in stress resilience and anxiety. High levels of NPY have been associated with stress resilience in both animal models and human studies, including research on soldiers exposed to extreme military training. Conversely, low NPY levels correlate with increased vulnerability to stress-related disorders including post-traumatic stress disorder (PTSD). This has led to interest in NPY or Y receptor agonists as potential treatments for anxiety and PTSD.

NPY also has important cardiovascular effects, causing vasoconstriction and potentiating the effects of norepinephrine. In the sympathetic nervous system, NPY is co-released with norepinephrine from sympathetic nerve terminals during stress and exercise, contributing to blood pressure regulation. Additional functions include roles in circadian rhythm regulation, bone formation, and immune modulation, reflecting the extraordinary diversity of this neuropeptide's biological roles.

Research Uses & Applications

  • Research target for understanding appetite and obesity mechanisms
  • Investigated as a potential therapeutic for anxiety and PTSD based on its stress-resilience properties
  • Biomarker for stress vulnerability and resilience in clinical research
  • Target pathway for anti-obesity drug development (Y receptor antagonists)
  • Research into cardiovascular regulation and sympathetic nervous system function
  • Studied for roles in bone metabolism and circadian rhythm regulation

Key Research Findings

  • Central administration of NPY produced the most potent appetite-stimulating effect of any known endogenous molecule in rodent studies.
  • Studies of military personnel undergoing survival training showed that soldiers with higher NPY levels demonstrated significantly better stress performance and lower dissociation (Morgan et al., Biological Psychiatry, 2000).
  • Intranasal NPY administration in animal models showed anxiolytic effects and improved stress resilience without the sedation associated with benzodiazepines.
  • Y2 and Y5 receptor knockout mice showed reduced food intake and obesity resistance, supporting these receptors as anti-obesity targets.
  • Genome-wide association studies linked NPY gene variants to differences in stress reactivity, body mass index, and risk for mood disorders.

Risks & Side Effects

  • NPY is not currently used as a therapeutic agent; it is primarily a research and biomarker tool.
  • Exogenous NPY administration can cause significant appetite stimulation and weight gain.
  • Cardiovascular effects including vasoconstriction and blood pressure elevation limit systemic administration.
  • Blood-brain barrier penetration of exogenous NPY is limited, complicating central delivery.
  • Complex receptor pharmacology means that targeting specific NPY functions therapeutically is challenging.

Administration

Not routinely administered as a therapeutic agent. In research settings, NPY is administered intracerebroventricularly (ICV) or intranasally in animal studies. Intranasal delivery has been explored in human clinical research as a means to bypass the blood-brain barrier. Typical research doses vary widely by route and species. Available as a research reagent for laboratory studies.

Legal Status

Available as a research reagent from scientific suppliers. Not approved by the FDA or other regulatory agencies as a therapeutic drug. Not a controlled substance. Clinical research on intranasal NPY delivery is ongoing in academic settings, particularly for PTSD and anxiety.

Frequently Asked Questions

What is Neuropeptide Y?

A 36-amino acid neuropeptide that is one of the most abundant peptides in the central nervous system, involved in appetite regulation, stress responses, anxiety, and cardiovascular function.

What are the main uses of Neuropeptide Y?

The primary research applications of Neuropeptide Y include: Research target for understanding appetite and obesity mechanisms; Investigated as a potential therapeutic for anxiety and PTSD based on its stress-resilience properties; Biomarker for stress vulnerability and resilience in clinical research; Target pathway for anti-obesity drug development (Y receptor antagonists); Research into cardiovascular regulation and sympathetic nervous system function; Studied for roles in bone metabolism and circadian rhythm regulation.

What are the risks and side effects of Neuropeptide Y?

Documented risks and side effects include: NPY is not currently used as a therapeutic agent; it is primarily a research and biomarker tool.; Exogenous NPY administration can cause significant appetite stimulation and weight gain.; Cardiovascular effects including vasoconstriction and blood pressure elevation limit systemic administration.; Blood-brain barrier penetration of exogenous NPY is limited, complicating central delivery.; Complex receptor pharmacology means that targeting specific NPY functions therapeutically is challenging.. Always consult a healthcare professional before considering any peptide.

Is Neuropeptide Y legal?

Available as a research reagent from scientific suppliers. Not approved by the FDA or other regulatory agencies as a therapeutic drug. Not a controlled substance. Clinical research on intranasal NPY delivery is ongoing in academic settings, particularly for PTSD and anxiety.

How is Neuropeptide Y administered?

Not routinely administered as a therapeutic agent. In research settings, NPY is administered intracerebroventricularly (ICV) or intranasally in animal studies. Intranasal delivery has been explored in human clinical research as a means to bypass the blood-brain barrier. Typical research doses vary widely by route and species. Available as a research reagent for laboratory studies.

Related Peptides

Stay Updated on Peptide Research

Get the latest peptide research news and updates delivered to your inbox.

Important Disclaimer

The information on this page is for educational and informational purposes only. It is not intended as medical advice. Always consult a qualified healthcare professional before considering any peptide or supplement. 50 Best Limited does not endorse, recommend, or promote the use of any peptide for self-administration. Read our full disclaimer.